FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L206

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / SPONSORED ADS
Total 13F shares
398,596
Share change
-385,492
Total reported value
$2,538,669
Price per share
$6.37
Number of holders
13
Value change
-$1,114,963
Number of buys
9
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 35655L206?
CUSIP 35655L206 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q4 2023

As of 31 Dec 2023, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 398,596 shares. The largest 10 holders included UBS Group AG, Blue Owl Capital Holdings LP, JPMORGAN CHASE & CO, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, HARBOR CAPITAL ADVISORS, INC., SPHERA FUNDS MANAGEMENT LTD., NORTHERN TRUST CORP, 49 WEALTH MANAGEMENT, LLC, and RHUMBLINE ADVISERS. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.